NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

2 weeks ago

SANTA ANA, Calif., Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- NKGen Biotech, Inc. ( Nasdaq: NKGN ) ( "NKGen" or the "Company" ) , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer ( "NK" ) cell ...

Ticker	Sentiment	Impact
NKGN	Neutral	12 %